Singapore: NUS medical school developing Covid-19 vaccine with Monash University

The vaccine, called Clec9A-RBD, is modified from a cancer drug. It is the third coronavirus vaccine that Singapore is developing. - The Straits Times/Asian News Network

SINGAPORE, Sept 21 (The Straits Times/ANN): Researchers from the National University of Singapore (NUS) and Monash University in Australia are developing a Covid-19 vaccine that could be ready for clinical trials by the end of next year.

The vaccine, modified from a cancer drug, has undergone animal studies, and researchers are hoping to conduct clinical trials in Singapore and Australia.